Cardiac Effects Associated With Breast Cancer Treatment Appear Lower
Mar 14th 2008Drug InformationBreast Cancer
A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a “dose-dense” regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
